Mundipharma has achieved a first success in defending the patent on its Targin analgesic. The Regional Court of Munich granted interim injunctions against several generics manufacturers. Targin is the top-selling pharmaceutical product of Limburg-based Mundipharma, which obtained a European patent (EP 2425825B9) the subject of the dispute on 16 November 2016.
Representing Mundipharma
Rospatt Osten Pross (Düsseldorf): Thomas Musmann; Associates: Dr. Simon Klopschinski, Dr. André Sabellek
Maiwald (Munich): Dr Dirk Bühler, Dr Andreas Ledl (both patent attorneys)
Representing Krka/TAD Pharma
Bock legal (Frankfurt): Dr. Andreas Bock – well known in the field of pharmaceuticals
Hoffmann Eitle (Munich): Dr. Martin Bachelin, Dr. Klemens Stratmann (both patent attorneys)
Representing Hexal and 1A Pharma
Taylor Wessing (Munich): Christoph de Coster – well known in the field of pharmaceuticals
Ter Meer Steinmeister & Partner (Munich): Dr. Bernd Aechter – well known in the field of pharmaceuticals
The complete Juve article can be downloaded under: https://www.juve.de/nachrichten/verfahren/2017/06/schmerzmittel-mundipharma-gelingt-etappensieg-mit-rospatt-und-maiwald-um-targin
